Expression of miRNA‑26a in platelets is associated with clopidogrel resistance following coronary stenting

  • Authors:
    • Shuxia Chen
    • Xiaoyong Qi
    • Hua Chen
    • Mingquan Li
    • Jian Gu
    • Chunxia Liu
    • Hua Xue
    • Lili Wang
    • Yanping Geng
    • Peng Qi
    • Yuping Han
  • View Affiliations

  • Published online on: April 20, 2016     https://doi.org/10.3892/etm.2016.3278
  • Pages: 518-524
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to evaluate the association between platelet microRNA (miRNA)‑26a expression and clopidogrel resistance in patients who underwent coronary stenting. Between September 2013 and August 2014, 43 patients with coronary heart disease underwent percutaneous coronary intervention at Heibei General Hospital (Shijiazhuang, China). In the same period, 20 healthy volunteers without any history of cardiovascular disease were enrolled in the present study as the control group. Flow cytometry was used to measure the phosphorylation levels of vasodilator‑stimulated phosphoprotein (VASP), and to calculate the platelet reactivity index (PRI). Low response to clopidogrel was defined as PRI ≥50% on day 7 following clopidogrel administration. Western blotting was used to measure protein expression of VASP and reverse transcription‑quantitative polymerase chain reaction analysis was performed to determine the expression levels of mRNA and miRNAs. Bioinformatics tools were employed to predict that miR‑26a, miR‑199 and miR‑23a may target VASP mRNA. The results of the present study demonstrated that the activity of platelets in patients with low or high clopidogrel response was increased, as compared with healthy subjects. No differences in platelet VASP protein expression levels were detected between patients with high clopidogrel response and healthy subjects; whereas VASP protein expression was elevated in patients with low clopidogrel response. Furthermore VASP gene transcription was maintained at low levels in healthy subjects and patients with high clopidogrel response, whereas patients with low clopidogrel response exhibited increased VASP mRNA expression levels. Platelet expression of miRNA‑26a, but not miRNA‑199 or miRNA‑23a, was associated with high platelet reactivity. Serum miRNA‑26a, miRNA‑199 and miRNA‑23a were not demonstrated to be involved in clopidogrel resistance. Therefore, the present study demonstrated that platelet miRNA‑26a has an important role in clopidogrel resistance. Combined miRNA and VASP PRI tests may aid the early diagnosis and prediction of clopidogrel resistance.
View Figures
View References

Related Articles

Journal Cover

July-2016
Volume 12 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen S, Qi X, Chen H, Li M, Gu J, Liu C, Xue H, Wang L, Geng Y, Qi P, Qi P, et al: Expression of miRNA‑26a in platelets is associated with clopidogrel resistance following coronary stenting. Exp Ther Med 12: 518-524, 2016
APA
Chen, S., Qi, X., Chen, H., Li, M., Gu, J., Liu, C. ... Han, Y. (2016). Expression of miRNA‑26a in platelets is associated with clopidogrel resistance following coronary stenting. Experimental and Therapeutic Medicine, 12, 518-524. https://doi.org/10.3892/etm.2016.3278
MLA
Chen, S., Qi, X., Chen, H., Li, M., Gu, J., Liu, C., Xue, H., Wang, L., Geng, Y., Qi, P., Han, Y."Expression of miRNA‑26a in platelets is associated with clopidogrel resistance following coronary stenting". Experimental and Therapeutic Medicine 12.1 (2016): 518-524.
Chicago
Chen, S., Qi, X., Chen, H., Li, M., Gu, J., Liu, C., Xue, H., Wang, L., Geng, Y., Qi, P., Han, Y."Expression of miRNA‑26a in platelets is associated with clopidogrel resistance following coronary stenting". Experimental and Therapeutic Medicine 12, no. 1 (2016): 518-524. https://doi.org/10.3892/etm.2016.3278